Howard McLeod, PharmD, is Fred Eshelman Distinguished Professor of Pharmacogenomics and Individualized Therapy at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill and the director of the UNC Institute for Pharmacogenomics and Individualized Therapy. Dr McLeod holds additional appointments in the UNC School of Medicine and the Lineberger Cancer Center.
Dr. McLeod is the principal investigator for the CREATE Pharmacogenetics Research Network, a member of the NIH funded Pharmacogenetics Research Network, and is a member of the FDA Committee on Clinical Pharmacology. He directs the Pharmacogenetics for Every Nation Initiative that aims to help developing countries use genetic information to improve National Drug Formulary decisions. McLeod has published more than 350 peer-reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to integrate genetics principles into clinical practice to advance individualized medicine.
McLeod completed research fellowship training in cancer pharmacology at St. Jude Children’s Research Hospital in Memphis and at the University of Glasgow in Scotland before becoming the director of the clinical pharmacology program at the Beatson Cancer Centre in Glasgow. He then became a senior lecturer in medicine and director of laboratory research for the oncology unit at the University of Aberdeen in Scotland. McLeod returned to the United States in 2000 to accept a position at Washington University in St. Louis, Missouri, where he was a professor in the Departments of Medicine, Pharmacology and Molecular Biology, and Genetics and director of the Siteman Cancer Center Pharmacology Core.Listen to an interview with Howard about Pharmacogenomics